Integra LifeSciences Holdings, a provider of medical devices, is engaged in the development, manufacturing, and marketing of surgical implants and medical instruments. Its products are used primarily in neurosurgery, reconstruction and general surgery. Co.'s segments are: Codman Specialty Surgical, which provides global, neurosurgery technologies, brands and instrumentation; and Orthopedics and Tissue Technologies, which address the needs of plastic, reconstructive and general surgeons focused on the treatment of acute wounds, such as burns, chronic wounds, including diabetic foot ulcers, and surgical tissue repair, such as hernia, tendon, peripheral nerve repair and protection. We show 51 historical shares outstanding datapoints in our IART shares outstanding history coverage, used to compute IART market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing IART market cap history over the course of time is important for investors
interested in comparing IART's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of IART versus a peer is one thing; comparing
IART market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like IART can fluctuate over the course of history.
With this page we aim to empower investors researching IART by allowing them to research the IART market cap history. |